In our collected cases, IL-17A was observed to be expressed in lung squamous carcinoma, adenocarcinoma, and lymphoepithelioma-like carcinoma, and mainly expressed in the cytoplasm and nucleus of tumor cells (Fig. 1B). Here, IL17A is linked to nasopharyngeal type undifferentiated carcinoma.